Clinical Trial Update: A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons [Phase 4]

View source ↗

Summary

This document notes the completion of a Phase 4 clinical trial evaluating valacyclovir to suppress herpes simplex virus shedding and HIV shedding in coinfected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Herpes Simplex Virus Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: University of Washington | Conditions: Herpes Simplex, HIV Infections | Phase 4 | Status: COMPLETED